Literature DB >> 28282627

Anti-NMDAR encephalitis followed by seropositive neuromyelitis optica spectrum disorder: A case report and literature review.

Ye Ran1, Lu Wang2, Fangfang Zhang1, Ran Ao1, Zhao Dong3, Shengyuan Yu4.   

Abstract

Neuromyelitis optica spectrum disorder (NMOSD) is an inflammatory central nervous system syndrome, and encephalitis associated with anti-N-methyl-d-aspartate receptor (NMDAR) antibodies is an autoimmune encephalopathy. A patient with both diseases, separately or simultaneously, is rare as a clinical phenomenon, but cannot be ignored. We report the clinical characteristics and imaging features of a special case with anti-NMDAR encephalitis followed by NMOSD. We subsequently reviewed the English language literature about demyelinating disorders with anti-NMDAR encephalitis. Details of the 34 patients identified are summarized and compared. There may be a connection between anti-NMDAR encephalitis and NMOSD.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  AQP4-IgG; Anti-NMDAR antibodies; Encephalitis, NMOSD

Mesh:

Substances:

Year:  2017        PMID: 28282627     DOI: 10.1016/j.clineuro.2017.02.016

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  6 in total

1.  Anti-N-methyl-D-aspartate receptor encephalitis following neuromyelitis optica spectrum disorders: a case report.

Authors:  Botao Huang; Sulian Su; Ning Han; Wei Wang
Journal:  Neurol Sci       Date:  2021-02-27       Impact factor: 3.307

2.  Life After Tetra Hit: Anti-NMDAR Encephalitis After HSV Encephalitis in a NMOSD Coexistent with Sjögren's Syndrome.

Authors:  Cansu Ayvacioğlu Çağan; Rahşan Göçmen; Nazire Pınar Acar Özen; Aslı Tuncer
Journal:  Noro Psikiyatr Ars       Date:  2022-04-12       Impact factor: 1.066

Review 3.  Clinical Characteristics of Anti-N-Methyl-d-Aspartate Receptor Encephalitis Overlapping with Demyelinating Diseases: A Review.

Authors:  Shujiang Zhang; Yuan Yang; Wenyu Liu; Zuoxiao Li; Jinmei Li; Dong Zhou
Journal:  Front Immunol       Date:  2022-06-28       Impact factor: 8.786

4.  Long-term persistence of NMDAR antibodies after encephalitis with de novo occurrence of demyelinating disorder.

Authors:  Maria Tappatà; Patrizia Riguzzi; Lilia Volpi; Luca Albini Riccioli; Roberta Pantieri; Roberto Michelucci
Journal:  Neurol Sci       Date:  2020-09-28       Impact factor: 3.307

Review 5.  Complexity and wide range of neuromyelitis optica spectrum disorders: more than typical manifestations.

Authors:  Jinming Han; Meng-Ge Yang; Jie Zhu; Tao Jin
Journal:  Neuropsychiatr Dis Treat       Date:  2017-10-20       Impact factor: 2.570

6.  Anti-NMDA receptor encephalitis concomitant with myelin oligodendrocyte glycoprotein antibody diseases: A retrospective observational study.

Authors:  Li Du; Huabing Wang; Heng Zhou; Haoxiao Chang; Yuzhen Wei; Hengri Cong; Wangshu Xu; Yuetao Ma; Tian Song; Xinghu Zhang; Linlin Yin
Journal:  Medicine (Baltimore)       Date:  2020-07-31       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.